Evidence for central regulation of glucose metabolism

Journal of Biological Chemistry

Volumn 288, Issue 49, 2013, Pages 35387-35395

  Carey, Michelle ^a   Kehlenbrink, Sylvia ^a   Hawkins, Meredith ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE PRODUCTION; HUMAN STUDY; METABOLIC CONDITIONS; METABOLIC REGULATIONS; WHOLE BODY;

METABOLISM; PHYSIOLOGY;

GLUCOSE;

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ADENYLATE KINASE; FATTY ACID; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LONG CHAIN FATTY ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT3 PROTEIN;

ARTICLE; DIABETES MELLITUS; DOWN REGULATION; ENERGY CONSUMPTION; ENZYME ACTIVITY; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; METABOLIC REGULATION; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84890276779     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R113.506782     Document Type: Article

References (36)

1. Vafai, S. B., and Mootha, V. K. (2012) Mitochondrial disorders as windows into an ancient organelle. Nature 491, 374-383
2. Armstrong, J. S. (2007) Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br. J. Pharmacol. 151, 1154-1165
3. Dykens, J. A., and Will, Y. (2007) The significance of mitochondrial toxicity testing in drug development. Drug Discov. Today 12, 777-785
4. Gohil, V. M., Sheth, S. A., Nilsson, R., Wojtovich, A. P., Lee, J. H., Perocchi, F., Chen, W., Clish, C. B., Ayata, C., Brookes, P. S., and Mootha, V. K. (2010) Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis. Nat. Biotechnol. 28, 249-255
5. Gohil, V. M., Offner, N., Walker, J. A., Sheth, S. A., Fossale, E., Gusella, J. F., MacDonald, M. E., Neri, C., and Mootha, V. K. (2011) Meclizine is neuroprotective in models of Huntington's disease. Hum. Mol. Genet. 20, 294-300
6. Cohen, B., and DeJong, J. M. (1972) Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study. Arch. Neurol. 27, 129-135
7. Kubo, N., Shirakawa, O., Kuno, T., and Tanaka, C. (1987) Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. Jpn. J. Pharmacol. 43, 277-282
8. Huang, W., Zhang, J., Wei, P., Schrader, W. T., and Moore, D. D. (2004) Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR. Mol. Endocrinol. 18, 2402-2408
9. Shaham, O., Slate, N. G., Goldberger, O., Xu, Q., Ramanathan, A., Souza, A. L., Clish, C. B., Sims, K. B., and Mootha, V. K. (2010)Aplasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc. Natl. Acad. Sci. U.S.A. 107, 1571-1575
10. Roberts, L. D., Souza, A. L., Gerszten, R. E., and Clish, C. B. (2012) Targeted metabolomics. Curr. Protoc. Mol. Biol. Chapter 30, Unit 30.2.1-24
11. Zhu, L., Johnson, C., and Bakovic, M. (2008) Stimulation of the human CTP:phosphoethanolamine cytidylyltransferase gene by early growth response protein 1. J. Lipid Res. 49, 2197-2211
12. Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
13. Tie, A., and Bakovic, M. (2007) Alternative splicing of CTP:phosphoethanolamine cytidylyltransferase produces two isoforms that differ in catalytic properties. J. Lipid Res. 48, 2172-2181
14. Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., Carpenter, A. E., Foo, S. Y., Stewart, S. A., Stockwell, B. R., Hacohen, N., Hahn, W. C., Lander, E. S., Sabatini, D. M., and Root, D. E. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298
15. Gohil, V. M., Nilsson, R., Belcher-Timme, C. A., Luo, B., Root, D. E., and Mootha, V. K. (2010) Mitochondrial and nuclear genomic responses to loss of LRPPRC expression. J. Biol. Chem. 285, 13742-13747
16. Will, Y., Hynes, J., Ogurtsov, V. I., and Papkovsky, D. B. (2006) Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat. Protoc. 1, 2563-2572
17. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509
18. Bartlett, G.R. (1959) Phosphorus assay in column chromatography. J. Biol. Chem. 234, 466-468
19. Webhofer, C., Gormanns, P., Tolstikov, V., Zieglgänsberger, W., Sillaber, I., Holsboer, F., and Turck, C. W. (2011) Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation. Transl. Psychiatry 1, e58
20. Watkins, S. M., and German, J. B. (2002) Metabolomics and biochemical profiling in drug discovery and development. Curr. Opin. Mol. Ther. 4, 224-228
21. Vance, J. E. (2008) Phosphatidylserine and phosphatidylethanolamine in mammalian cells: two metabolically related aminophospholipids. J. Lipid Res. 49, 1377-1387
22. Pavlovic, Z., and Bakovic, M. (2013) Regulation of phosphatidylethanolamine homeostasis - the critical role of CTP: phosphoethanolamine cytidylyltransferase (Pcyt2). Int. J. Mol. Sci. 14, 2529-2550
23. Modica-Napolitano, J. S., and Renshaw, P. F. (2004) Ethanolamine and phosphoethanolamine inhibit mitochondrial function in vitro: implications for mitochondrial dysfunction hypothesis in depression and bipolar disorder. Biol. Psychiatry 55, 273-277
24. Tasseva, G., Bai, H. D., Davidescu, M., Haromy, A., Michelakis, E., and Vance, J. E. (2013) Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J. Biol. Chem. 288, 4158-4173
25. Fullerton, M. D., Hakimuddin, F., Bonen, A., and Bakovic, M. (2009) The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice. J. Biol. Chem. 284, 25704-25713
26. Gohil, V. M., Thompson, M. N., and Greenberg, M. L. (2005) Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine and cardiolipin biosynthetic pathways in Saccharomyces cerevisiae. J. Biol. Chem. 280, 35410-35416
27. Jiang, F., Ryan, M. T., Schlame, M., Zhao, M., Gu, Z., Klingenberg, M., Pfanner, N., and Greenberg, M. L. (2000) Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J. Biol. Chem. 275, 22387-22394
28. Steenbergen, R., Nanowski, T. S., Beigneux, A., Kulinski, A., Young, S. G., and Vance, J. E. (2005) Disruption of the phosphatidylserine decarboxylase gene in mice causes embryonic lethality and mitochondrial defects. J. Biol. Chem. 280, 40032-40040
29. Bleijerveld, O. B., Brouwers, J. F., Vaandrager, A. B., Helms, J. B., and Houweling, M. (2007) The CDP-ethanolamine pathway and phosphatidylserine decarboxylation generate different phosphatidylethanolamine molecular species. J. Biol. Chem. 282, 28362-28372
30. Böttinger, L., Horvath, S. E., Kleinschroth, T., Hunte, C., Daum, G., Pfanner, N., and Becker, T. (2012) Phosphatidylethanolamine and cardiolipin differentially affect the stability of mitochondrial respiratory chain supercomplexes. J. Mol. Biol. 423, 677-686
31. Weiss, W. A., Taylor, S. S., and Shokat, K. M. (2007) Recognizing and exploiting differences between RNAi and small-molecule inhibitors. Nat. Chem. Biol. 3, 739-744
32. Ferreira, A. K., Meneguelo, R., Pereira, A., Mendonça Filho, O., Chierice, G. O., and Maria, D. A. (2012) Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: An experimental study. Anticancer Res. 32, 95-104
33. Kelly, R. F., Lamont, K. T., Somers, S., Hacking, D., Lacerda, L., Thomas, P., Opie, L. H., and Lecour, S. (2010) Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res. Cardiol. 105, 763-770
34. Gibellini, F., Hunter, W. N., and Smith, T. K. (2009) The ethanolamine branch of the Kennedy pathway is essential in the bloodstream form of Trypanosoma brucei. Mol. Microbiol. 73, 826-843
35. Maheshwari, S., Lavigne, M., Contet, A., Alberge, B., Pihan, E., Kocken, C., Wengelnik, K., Douguet, D., Vial, H., and Cerdan, R. (2013) Biochemical characterization of Plasmodium falciparum CTP:phosphoethanolamine cytidylyltransferase shows that only one of the two cytidylyltransferase domains is active. Biochem. J. 450, 159-167
36. Wang, Z., Lee, B., Pearce, D., Qian, S., Wang, Y., Zhang, Q., and Chow, M. S. (2012) Meclizine metabolism and pharmacokinetics: formulation on its absorption. J. Clin. Pharmacol. 52, 1343-1349.